This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Aug;151(2):108-10.

doi: 10.1016/j.jpeds.2007.04.035.

Newborn screening: the spigot is open and threatens to become a flood

Stephen Cederbaum

PMID: 17643755
DOI: 10.1016/j.jpeds.2007.04.035

Editorial

Newborn screening: the spigot is open and threatens to become a flood

Stephen Cederbaum. J Pediatr. 2007 Aug.

. 2007 Aug;151(2):108-10.

doi: 10.1016/j.jpeds.2007.04.035.

Author

Stephen Cederbaum

PMID: 17643755
DOI: 10.1016/j.jpeds.2007.04.035

No abstract available

PubMed Disclaimer

Comment on

Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands.
van der Hilst CS, Derks TG, Reijngoud DJ, Smit GP, TenVergert EM. van der Hilst CS, et al. J Pediatr. 2007 Aug;151(2):115-20, 120.e1-3. doi: 10.1016/j.jpeds.2007.03.013. J Pediatr. 2007. PMID: 17643759
Healthcare use and costs of medium-chain acyl-CoA dehydrogenase deficiency in Australia: screening versus no screening.
Haas M, Chaplin M, Joy P, Wiley V, Black C, Wilcken B. Haas M, et al. J Pediatr. 2007 Aug;151(2):121-6, 126.e1. doi: 10.1016/j.jpeds.2007.03.011. Epub 2007 Jun 14. J Pediatr. 2007. PMID: 17643760

Similar articles

Does newborn screening save money? The difference between cost-effective and cost-saving interventions.
Grosse SD. Grosse SD. J Pediatr. 2005 Feb;146(2):168-70. doi: 10.1016/j.jpeds.2004.10.015. J Pediatr. 2005. PMID: 15689900 No abstract available.
Newborn screening fact sheets. American Academy of Pediatrics. Committee on Genetics.
[No authors listed] [No authors listed] Pediatrics. 1996 Sep;98(3 Pt 1):473-501. Pediatrics. 1996. PMID: 8784381 No abstract available.
Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands.
van der Hilst CS, Derks TG, Reijngoud DJ, Smit GP, TenVergert EM. van der Hilst CS, et al. J Pediatr. 2007 Aug;151(2):115-20, 120.e1-3. doi: 10.1016/j.jpeds.2007.03.013. J Pediatr. 2007. PMID: 17643759
Newborn screening for metabolic disorders.
Marsden D, Larson C, Levy HL. Marsden D, et al. J Pediatr. 2006 May;148(5):577-584. doi: 10.1016/j.jpeds.2005.12.021. J Pediatr. 2006. PMID: 16737864 Review. No abstract available.
Newborn screening for genetic disorders.
Fernhoff PM. Fernhoff PM. Pediatr Clin North Am. 2009 Jun;56(3):505-13, Table of Contents. doi: 10.1016/j.pcl.2009.03.002. Pediatr Clin North Am. 2009. PMID: 19501689 Review.

See all similar articles

Cited by

Public support for neonatal screening for Pompe disease, a broad-phenotype condition.
Weinreich SS, Rigter T, van El CG, Dondorp WJ, Kostense PJ, van der Ploeg AT, Reuser AJ, Cornel MC, Hagemans ML. Weinreich SS, et al. Orphanet J Rare Dis. 2012 Mar 14;7:15. doi: 10.1186/1750-1172-7-15. Orphanet J Rare Dis. 2012. PMID: 22413814 Free PMC article.
Advances in the treatment of fragile X syndrome.
Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, Kronk R, Delahunty C, Hessl D, Visootsak J, Picker J, Gane L, Tranfaglia M. Hagerman RJ, et al. Pediatrics. 2009 Jan;123(1):378-90. doi: 10.1542/peds.2008-0317. Pediatrics. 2009. PMID: 19117905 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information